Annual Long Term Debt
$1.27 B
-$328.39 M-20.50%
31 December 2023
Summary:
Sarepta Therapeutics annual long term debt is currently $1.27 billion, with the most recent change of -$328.39 million (-20.50%) on 31 December 2023. During the last 3 years, it has risen by +$135.09 million (+11.87%). SRPT annual long term debt is now -20.50% below its all-time high of $1.60 billion, reached on 31 December 2022.SRPT Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.31 B
+$27.56 M+2.16%
30 September 2024
Summary:
Sarepta Therapeutics quarterly long term debt is currently $1.31 billion, with the most recent change of +$27.56 million (+2.16%) on 30 September 2024. Over the past year, it has increased by +$32.49 million (+2.55%). SRPT quarterly long term debt is now -18.47% below its all-time high of $1.60 billion, reached on 31 December 2022.SRPT Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.5% |
| 3 y3 years | +11.9% | +14.7% |
| 5 y5 years | +74.5% | +79.0% |
SRPT Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.5% | +11.9% | -18.5% | +14.8% |
| 5 y | 5 years | -20.5% | +74.5% | -18.5% | +79.0% |
| alltime | all time | -20.5% | >+9999.0% | -18.5% | >+9999.0% |
Sarepta Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.31 B(+2.2%) |
| June 2024 | - | $1.28 B(+0.4%) |
| Mar 2024 | - | $1.27 B(+0.0%) |
| Dec 2023 | $1.27 B(-20.5%) | $1.27 B(-7.1%) |
| Sept 2023 | - | $1.37 B(+0.5%) |
| June 2023 | - | $1.36 B(+5.9%) |
| Mar 2023 | - | $1.29 B(-19.6%) |
| Dec 2022 | $1.60 B(+40.7%) | $1.60 B(+1.5%) |
| Sept 2022 | - | $1.58 B(+38.4%) |
| June 2022 | - | $1.14 B(+0.2%) |
| Mar 2022 | - | $1.14 B(-0.1%) |
| Dec 2021 | $1.14 B(+6.1%) | $1.14 B(-1.7%) |
| Sept 2021 | - | $1.16 B(+0.0%) |
| June 2021 | - | $1.16 B(+0.6%) |
| Mar 2021 | - | $1.15 B(+7.4%) |
| Dec 2020 | $1.07 B(+47.0%) | $1.07 B(+39.6%) |
| Sept 2020 | - | $768.70 M(+0.3%) |
| June 2020 | - | $766.56 M(+1.8%) |
| Mar 2020 | - | $753.22 M(+3.2%) |
| Dec 2019 | $729.62 M(+73.5%) | $729.62 M(+50.1%) |
| Sept 2019 | - | $486.16 M(+1.0%) |
| June 2019 | - | $481.25 M(+0.7%) |
| Mar 2019 | - | $477.92 M(+13.6%) |
| Dec 2018 | $420.55 M(-1.0%) | $420.55 M(+1.2%) |
| Sept 2018 | - | $415.45 M(-3.4%) |
| June 2018 | - | $429.93 M(+0.6%) |
| Mar 2018 | - | $427.37 M(+0.6%) |
| Dec 2017 | $424.88 M(+6932.0%) | $424.88 M(+1500.3%) |
| Sept 2017 | - | $26.55 M(+1033.2%) |
| Mar 2017 | - | $2.34 M(-61.2%) |
| Dec 2016 | $6.04 M(-59.6%) | $6.04 M(-28.8%) |
| Sept 2016 | - | $8.49 M(-16.0%) |
| June 2016 | - | $10.11 M(-24.4%) |
| Mar 2016 | - | $13.37 M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $14.97 M(+300.5%) | $14.97 M(-14.0%) |
| Sept 2015 | - | $17.40 M(-15.8%) |
| June 2015 | - | $20.65 M(+1324.3%) |
| Mar 2015 | - | $1.45 M(-61.2%) |
| Dec 2014 | $3.74 M(+137.2%) | $3.74 M(-0.7%) |
| Sept 2014 | - | $3.76 M(+146.8%) |
| June 2014 | - | $1.52 M(-1.7%) |
| Mar 2014 | - | $1.55 M(-1.6%) |
| Dec 2013 | $1.58 M(-5.5%) | $1.58 M(-1.4%) |
| Sept 2013 | - | $1.60 M(-1.4%) |
| June 2013 | - | $1.62 M(-1.4%) |
| Mar 2013 | - | $1.65 M(-1.4%) |
| Dec 2012 | $1.67 M(-5.1%) | $1.67 M(-1.3%) |
| Sept 2012 | - | $1.69 M(-1.3%) |
| June 2012 | - | $1.71 M(-1.3%) |
| Mar 2012 | - | $1.74 M(-1.3%) |
| Dec 2011 | $1.76 M(-4.6%) | $1.76 M(-1.2%) |
| Sept 2011 | - | $1.78 M(-1.2%) |
| June 2011 | - | $1.80 M(-1.2%) |
| Mar 2011 | - | $1.82 M(-1.1%) |
| Dec 2010 | $1.84 M(-4.3%) | $1.84 M(-1.1%) |
| Sept 2010 | - | $1.86 M(-1.1%) |
| June 2010 | - | $1.88 M(-37.5%) |
| Mar 2010 | - | $3.01 M(+56.5%) |
| Dec 2009 | $1.92 M(-23.5%) | $1.92 M(-1.3%) |
| Sept 2009 | - | $1.95 M(-23.3%) |
| June 2009 | - | $2.54 M(+1.2%) |
| Mar 2009 | - | $2.51 M(-0.2%) |
| Dec 2008 | $2.52 M(+21.5%) | $2.52 M(+24.9%) |
| Sept 2008 | - | $2.02 M(-0.9%) |
| June 2008 | - | $2.03 M(-3.1%) |
| Mar 2008 | - | $2.10 M(+1.3%) |
| Dec 2007 | $2.07 M | $2.07 M(-0.9%) |
| Sept 2007 | - | $2.09 M(-0.8%) |
| June 2007 | - | $2.11 M |
FAQ
- What is Sarepta Therapeutics annual long term debt?
- What is the all time high annual long term debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly long term debt year-on-year change?
What is Sarepta Therapeutics annual long term debt?
The current annual long term debt of SRPT is $1.27 B
What is the all time high annual long term debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual long term debt is $1.60 B
What is Sarepta Therapeutics quarterly long term debt?
The current quarterly long term debt of SRPT is $1.31 B
What is the all time high quarterly long term debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly long term debt is $1.60 B
What is Sarepta Therapeutics quarterly long term debt year-on-year change?
Over the past year, SRPT quarterly long term debt has changed by +$32.49 M (+2.55%)